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Perﬂuorinated compounds (PFCs) are widely
distributed in the environment. Particularly,
perﬂuorooctanesulfonate (PFOS) and perﬂu-
orooctanoate (PFOA) persist in humans and
the environment. PFCs have been identiﬁed
in surface water in the surroundings of ﬂuo-
rochemical production sites (Hansen et al.
2002), surface water from the Great Lakes
(USA) (Sinclair et al. 2006) and oceans
(Yamashita et al. 2005), wildlife (Giesy and
Kannan 2001), and even in biota from
remote regions (De Silva and Mabury 2004). 
Human biomonitoring has proved to be a
valuable tool to assess historical exposure to
PFCs (Butenhoff et al. 2006). PFOS and
PFOA have been detected in human blood
samples of occupational (Olsen et al. 2003,
2007) and general populations. Data from
the National Health and Nutrition
Examination Survey (NHANES) 2003–2004
have been reported by Calafat et al. (2007).
The authors observed reductions in the
PFOA, PFOS, and perﬂuorohexanesulfonate
(PFHxS) serum concentrations compared
with NHANES 1999–2000. In a study com-
paring different countries, the highest PFOS
concentrations were observed in blood plasma
samples collected from the United States and
Poland (> 30 µg/L); moderate in Korea,
Belgium, Malaysia, Brazil, Italy, and
Colombia (3–29 µg/L); and lowest in India
(< 3 µg/L) (Kannan et al. 2004). In Germany
recently, 12.2 µg PFOS/L and 5.3 µg
PFOA/L (median values) were found in
nonoccupationally exposed volunteers (14–67
years of age) living in the southern part of
Bavaria, Germany (Fromme et al. 2007a).
Midasch et al. (2006) reported 22.3 µg
PFOS/L and 6.8 µg PFOA/L (median values)
in 105 German nonsmokers. Human toxicol-
ogy for PFOA and PFOS has also been
reviewed recently [Kennedy et al. 2004; Kudo
and Kawashima 2003; Lau et al. 2007;
Organisation for Economic Co-operation and
Development (OECD) 2002]. 
Despite the well-documented background
exposure of the general population to PFCs,
the main sources are not well known. Dietary
intake seems to be the main source of expo-
sure of the general population to PFOS and
PFOA (Fromme et al. 2007b). To the best of
our knowledge, a specific contaminated
source has been described only in West
Virginia (USA). In 2006, Emmett et al. pub-
lished their investigations on PFOA contami-
nation of drinking water in the surroundings
of a fluoropolymer production site in
Washington, West Virginia. The public water
supply of Little Hocking, Ohio, draws water
from wells across the Ohio River and has
been contaminated by the highest PFOA
concentrations reported in drinking water of
public water supplies (mean, 3,550 ng/L;
range, 1,500–7,200 ng/L) (Emmett et al.
2006a). Recently, a retrospective exposure
assessment of the community was published
(Paustenbach et al. 2007).
During their investigations into PFC con-
centrations of surface waters in Germany,
Skutlarek et al. (2006) observed remarkably
high PFOA concentrations not only in the
rivers Ruhr (tributary of the Rhine, up to 177
ng/L) and Moehne (tributary of the Ruhr, up
to 7,070 ng/L), but also in public water sup-
plies, which use river water to produce drink-
ing water by bank filtration or artificial
recharge. The highest PFC concentration in
drinking water, which was reported by
Skutlarek et al., was 598 ng/L [sum of 519 ng
PFOA, 5 ng PFOS, 11 ng perﬂuorobutanoic
acid, 22 ng perfluorohexanoate (PFHxA),
5 ng perﬂuoropentanoic acid (PFPA), 23 ng
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OBJECTIVE: 40,000 residents in Arnsberg, Germany, had been exposed to drinking water contaminated
with perﬂuorinated compounds (PFCs). Internal exposure of the residents of Arnsberg to six PFCs was
assessed in comparison with reference areas. 
DESIGN AND PARTICIPANTS: One hundred seventy children (5–6 years of age), 317 mothers
(23–49 years), and 204 men (18–69 years) took part in the cross-sectional study. 
MEASUREMENTS: Individual consumption of drinking water and personal characteristics were
assessed by questionnaire and interview. Perfluorooctanoate (PFOA), perfluorooctanesulfonate
(PFOS), perfluorohexanoate, perfluorohexanesulfonate (PFHxS), perfluoropentanoate, and
perfluorobutanesulfonate (PFBS) in blood plasma and PFOA/PFOS in drinking water samples
were measured by solid-phase extraction, high-performance liquid chromatrography, and tandem
mass spectrometry detection. 
RESULTS: Of the various PFCs, PFOA was the main compound found in drinking water
(500–640 ng/L). PFOA levels in blood plasma of residents living in Arnsberg were 4.5–8.3 times
higher than those for the reference population (arithmetic means Arnsberg/controls: children
24.6/5.2 µg/L, mothers 26.7/3.2 µg/L, men 28.5/6.4 µg/L). Consumption of tap water at home
was a significant predictor of PFOA blood concentrations in Arnsberg. PFHxS concentrations
were signiﬁcantly increased in Arnsberg compared with controls (p < 0.05). PFBS was detected in
33% of the children, 4% of the women, and 13% of the men in Arnsberg compared with 5%,
0.7%, and 3%, respectively, in the reference areas (p < 0.05). Regression analysis showed that age
and male sex were signiﬁcant predictors of PFOS, PFOA, and PFHxS; associations of other regressors
(diet, body mass index) varied among PFCs.
CONCLUSIONS: PFC concentrations in blood plasma of children and adults exposed to PFC-
contaminated drinking water were increased 4- to 8-fold compared with controls. 
KEY WORDS: adults, children, drinking water, PFBS, PFC exposure, PFHxS, PFOA, PFOS. Environ
Health Perspect 116:651–657 (2008). doi:10.1289/ehp.11064 available via http://dx.doi.org/ [Online
20 February 2008]
Researchperﬂuoroheptanoic acid, and 13 ng perﬂuoro-
butane sulfonate (PFBS) per liter] in Arnsberg-
Neheim. The PFC concentrations in the
river Moehne in Arnsberg-Neheim (sum
value, 767 ng/L; PFOA, 647 ng/L) barely
exceeded the PFC levels in corresponding
drinking water (Skutlarek et al. 2006). In
July 2006, the waterworks of Moehnebogen
installed activated-charcoal ﬁlters, which efﬁ-
ciently decreased PFC concentrations in
drinking water. 
The ﬁnding of increased PFC concentra-
tions in surface and drinking waters initiated
an extensive environmental monitoring pro-
gram. Meanwhile, systematic analyses of soil,
ground, surface, and drinking water have
been performed to identify sources and to
assess human exposure to PFCs (Wilhelm
et al., in press). Immediately after the
increased PFOA levels were observed, the
German Drinking Water Commission (DWC)
of the German Ministry of Health at the
Federal Environment Agency established
guide values for human health protection
(DWC 2006; Wilhelm et al., in press). As a
result, local health authorities recommended
that residents in parts of Arnsberg not use the
drinking water for preparation of baby food,
and advised pregnant women to avoid regular
intake of such water. PFC-contaminated
(> 500 ng PFOA/L) drinking water was sup-
plied to approximately 40,000 residents
(Kleeschulte et al. 2007). No data are avail-
able on PFC levels in drinking water in
Arnsberg before May 2006. 
By tracking the PFC contamination in
the upper reaches of the river Moehne, the
drainage of agricultural land was identiﬁed as
the main source of contamination (Skutlarek
et al. 2006). Based on the results of the exten-
sive environmental monitoring program, fed-
eral health authorities concluded that PFC
contamination of agricultural land occurred
by the widespread use of soil conditioner,
which had been mingled with industrial
waste. Apparently PFC concentrations varied
considerably between batches of material:
Kraft et al. (2007) reported 650 µg PFOA
and 8,600 µg PFOS/kg dry weight. 
Between 2000 and 2006, farmers dissemi-
nated 27,700 tons of soil conditioner on
almost 800 agricultural land sites in the catch-
ment areas of the rivers Moehne and Upper-
Ruhr. Overall, 53,000 tons of the mixture
were applied to > 1,300 areas in North
Rhine–Westphalia (Delschen et al. 2007). All
areas in the catchment area of the rivers
Moehne and Upper-Ruhr where the particular
soil conditioner was disseminated were
screened for PFC contamination by analyzing
surface soil samples. In most soil samples, no
or low PFC concentrations were observed,
whereas in few cases high PFC concentrations
were found (District Government Arnsberg
2007). The most relevant PFC pollution
(6,300 µg PFOS + PFOA/kg) with respect to
drinking-water contamination was observed in
a 10 hectares–wide agricultural area in Brilon-
Scharfenberg (Bergmann et al., in press). The
area in Brilon-Scharfenberg drains into the
Steinbecke and Bermecke, small creeks that are
tributaries of the river Moehne. After installa-
tion of a special drainage around the area with
water treatment by activated-charcoal ﬁltering,
the PFC concentrations in the river Moehne
decreased distinctly. 
We report here on the results of a biomoni-
toring study performed between September and
November 2006. The study was designed to
determine the concentrations of PFCs in blood
plasma of subjects affected by PFOA contami-
nation of public water supplies compared with
reference areas; explore the association between
personal drinking-water consumption and the
concentrations of PFCs in blood plasma; and
explore the association between diet (consump-
tion of locally grown fruits and vegetables,
locally caught ﬁsh) and the concentrations of
PFCs in blood plasma.
Study Design, Population, and
Methods
The cross-sectional study was performed
between September and November 2006 in
Arnsberg, Siegen, and Brilon. Arnsberg
(75,000 inhabitants) and Brilon (25,000
inhabitants) are located in the eastern part
of North Rhine–Westphalia, known as
“Hochsauerland,” which is an important
recreation area for the state. Siegen (100,000
inhabitants) lies in the south Westphalian
part of North Rhine–Westphalia. 
Study areas were predeﬁned on the basis of
the water supply system structure and PFC
water analyses. Four (of 15) boroughs in
Arnsberg had been constantly supplied by the
Moehnebogen waterworks with PFOA-conta-
minated drinking water: Neheim, Huesten,
Herdringen, and Bruchhausen. These bor-
oughs were selected as the target area and are
referred to here as “Arnsberg.” PFOA or
PFOS could not be detected in drinking-water
samples in the reference areas Brilon and
Siegen (Figure 1).
Study population. Male adults were
recruited from age-stratiﬁed random samples
of the male population 18–69 years of age in
Arnsberg (n = 14,167) and Brilon (n =
8,608), respectively. Home addresses were
provided by the registration of address ofﬁce.
Randomly selected subjects (Arnsberg, 527;
Brilon, 500) were informed in writing and
subsequently contacted by telephone for a
short interview to assess personal consump-
tion of drinking water. At least three attempts
were made to contact the addressed persons.
Contact was successful for 234 men in
Arnsberg and 296 in Brilon. Of those men
contacted, 199 (85%) in Arnsberg and 200
(68%) in Brilon answered the questionnaire
and consented to participate. Based on the
evaluation of the questionnaire data, 100 men
with the highest self-reported tap water con-
sumption were selected to participate in
Arnsberg and Brilon, respectively. 
For the recruitment of mothers and chil-
dren, we chose a different approach. Parents of
all school beginners in the affected districts
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Figure 1. Location of study and reference areas and PFOA and PFOS concentrations in drinking water. All
analyses were performed by North Rhine–Westphalia State Agency for Nature, Environment and
Consumer Protection except those marked by an asterisk, which were analyzed and reported by Skutlarek
et al. (2006). ND, not detected. Tap-water samples were collected from the kitchen at the homes of the
residents; analyses were performed for every day that blood samples were taken during the study period.
In July 2006, waterworks installed activated charcoal ﬁlters. LOD = 10 ng/L. 
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were informed in writing and asked to partici-
pate. Contact was successful with 217 mothers
(60%) in Arnsberg and 262 (63%) in Siegen.
Of those contacted, 164 (76%) in Arnsberg
and 153 (58%) in Siegen ﬁnally participated.
Informed consent was obtained from the
participants and the parents of the children
before the study. The study was approved by
the ethical commission of the Ruhr-University
of Bochum and was conducted in accordance
with the ethical principles for medical research
involving human subjects as defined by the
Helsinki Declaration.
Questionnaire. A questionnaire for self-
completion was sent to the study participants
to obtain information on characteristics such
as height, body weight, school education,
smoking habits, exposure to environmental
tobacco smoke, and environmental or occupa-
tional exposures to PFCs. On the date the
blood samples were taken, trained interviewers
administered a standardized questionnaire
on drinking-water consumption and diet.
Drinking-water consumption was itemized
as follows: pure water, tea or coffee, prepara-
tions with juice concentrates, and soups.
Consumption at home and at the workplace (or
at kindergarten for the children) were recorded
separately. To account for temporal changes in
consumer behavior, actual as well as past drink-
ing-water consumption was recorded. Parents
answered questions for their children. 
Sampling of blood and drinking water.
Blood collection began on 4 September and
ended 22 November 2006. Standard materi-
als for venipuncture and blood sampling were
used. Blood samples were processed on the
same day. Plasma samples were stored at
–20°C and transported frozen to the analyti-
cal toxicologic laboratories in Erlangen,
Germany. All materials were tested for PFC
contamination before the start of the study.
No contamination was found. 
Tap-water samples were collected from
the kitchen in the homes of all residents.
Sampling vessels (polypropylene, 50 mL;
Greiner Bio-One, Frickenhausen, Germany)
were thoroughly rinsed with methanol before
use. On the day the blood samples were
drawn, tap-water samples were taken by the
study participants following written instruc-
tions. Water samples were frozen, stored at
–20°C, and transported to the laboratories for
further processing. One random water sample
per day was analyzed. 
Both laboratories (for blood and water
analyses) were blinded with respect to the ori-
gin of the samples and performed the analyses
after the end of the ﬁeld phase.
Analysis of blood plasma. Human plasma
samples were analyzed for PFOS, PFHxS,
PFBS, PFOA, PFHxA, and PFPA. The
analytes were extracted from interfering
matrix compounds by solid-phase extraction
(Taniyasu et al. 2005). After elution, the ana-
lytes were chromatographically separated by
high performance liquid chromatography
(HPLC) and detected by tandem mass spec-
trometry. Calibration was performed using
standard solutions prepared in bovine serum
which were treated in the same manner as the
human plasma samples analyzed. As internal
standards, 13C-labeled analogs of PFOS,
PFOA, and PFHxA were used.
Five hundred microliters of the plasma
aliquot was spiked with 50 µL internal stan-
dard solution [1,2,3,4-13C4-PFOS and
1,2-13C2-PFHxA (Wellington Laboratories,
Guelph, Ontario, Canada) and 1,2-13C2-
PFOA (Medical Laboratory, Bremen,
Germany); concentrations were 250 µg/L in
acetonitrile]. To precipitate plasma proteins,
2 mL formic acid (50% aq., vol/vol) were
added, and the sample was sonicated for
15 min. After centrifugation, the supernatant
was used for solid-phase extraction on a
Waters Oasis WAX cartridge (Waters GmbH,
Eschborn, Germany), which was precondi-
tioned with 2 mL methanol and 2 mL water
(Taniyasu et al. 2005). After drawing the sam-
ple through, the cartridge was rinsed with
2 mL methanol solution (40% aq., vol/vol).
Elution was obtained by 1 mL 2% NH4OH in
methanol. The eluate was dried under a stream
of nitrogen to a volume of approximately
100 µL and diluted afterward with 75 µL
ammonium acetate solution (20 mmol aq.) in
methanol (25/75, vol/vol). Chromatographic
separation was performed on an Agilent
Zorbax Eclipse XDB-C8 column (GGA
GmbH, Moers, Germany). For detection, an
Applied Biosystems API 2000 triple quadru-
pole mass spectrometer (Foster City, CA,
USA) was operated in negative electrospray
ionization (ESI) and multiple reaction moni-
toring (MRM) modes. In each analytical
batch, one reagent blank (water instead of
plasma), one serum blank, the calibration stan-
dards [all standard substances purchased from
Sigma-Aldrich (Taufkirchen, Germany), con-
centration of the analytes 2.5 to 50 µg/L, pre-
pared in bovine serum], and one quality
control sample were analyzed parallel to the
human plasma samples. Reagent blanks were
subtracted from the obtained plasma concen-
trations. Limits of detection were estimated to
be 0.1 µg/L for PFOS, PFHxS, PFBS, and
PFOA, and 1.0 µg/L for PFHxA and PFPA
based on a 3-fold signal-to-noise ratio. Quality
control of the analytical results was carried out
as stipulated in the guidelines of the German
Medical Association for quality assurance of
quantitative analyses in laboratory medicine
(Bundesaerztekammer 2001).
Within-series imprecision was determined
by analyzing a pooled human plasma sample
spiked with PFHxS, PFBS, PFHxA, and
PFPA (∼ 5 µg/L each). For PFOS and PFOA
the native concentrations were measured
(~ 9.5 and 5.5 µg/L, respectively). The coefﬁ-
cients of variation (CVs) were between 4.4
and 10.9% at 10 repetitions. The between-day
imprecision was determined by analyzing the
same material 49 times on different days (2–3
times/day). The CVs thereby ranged from 6.9
to 12.7%. Depending on the analyte, mean
relative recoveries were between 101.9 and
122.0% at a spiked concentration of 10 µg/L
using ﬁve different plasma samples. 
Analysis of drinking water. Forty milli-
liters of the water sample was spiked with
internal standard substances (13C4-PFOA,
13C4-PFOS). Solid-phase extraction was per-
formed on a modified polymer cartridge
(Isolute ENV+; 25 mg; Separtis GmbH,
Grenzach-Wyhlen, Germany), which was
preconditioned with 2 mL methanol and
2 mL water; 10 mL of the prepared water
sample was passed through. After a washing
step with 2 mL water, the adsorbent material
was dried in the airﬂow. Analytes were eluted
with 1.5 mL methanol and reduced to dry-
ness under nitrogen gas flow at 40°C and
then solved in 1 mL of a mixture of water/
methanol (8/2, vol/vol).
PFCs were separated by HPLC by gradi-
ent elution on an RP-C18 phase using an
acetate buffer solution in methanol and water.
Compounds were detected with a tandem
quadrupole mass spectrometer employing ESI
in negative mode and MRM. 
We identiﬁed PFCs by the retention time
and the intensity coefﬁcient of two mass transi-
tions for each compound. Calibration was per-
formed with internal standard evaluation. The
linear concentration range was 0.1–2.5 ng/mL.
The reference standard solutions (linear com-
pounds only) were purchased from Wellington
Laboratories. The signal of the isomer part was
calculated on the base of the response of the
linear compound. The results are given as the
sum of the concentration of all identiﬁed linear
and branched isomers. The limit of detection
(LOD) was 10 ng/L (signal to noise > 10:1,
peak-to-peak mode). 
We analyzed the blank of the whole pro-
cedure within every sample series; in all series
it was < 2 ng/L for PFOA and PFOS. We
determined the measurement uncertainty by
standard addition method; it was < 20% at a
concentration level of 100 ng/L. Typical
method recoveries were 98.5 ± 1.9% (n = 6)
for PFOA and 85.1 ± 4.1% (n = 6) for PFOS,
calculated by external standardization. The
method for PFC analysis in drinking water is
described in International Organization for
Standardization (ISO)/CD 25101 (ISO 2008).
Data and statistical methods. For PFC con-
centrations below the LOD, an imputed value
equal to one-half the LOD was used. Minima,
lower quartiles, medians, upper quartiles,
PFC biomonitoring in children and adults
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conﬁdence intervals) of the PFCs in Arnsberg
and in controls are presented in box and
whisker plots. 
Geometric mean levels are presented
because most of the distributions are not nor-
mal but “skewed to the right,” i.e., higher
values. We calculated Spearman rank correla-
tion coefﬁcients (rS) to evaluate the closeness of
relationship between two continuous variables. 
We performed multivariate analyses
through linear regression models. Dependent
variables were log10(PFOA, PFOS, PFHxS)
concentrations in blood plasma (nanograms
per liter). Regressors were chosen based on
the study hypothesis (region, consumption of
drinking water, locally caught fish, locally
grown fruits and vegetables), other studies
(age, sex), and the results of bivariate calcula-
tions [body mass index (BMI)]. Additionally,
we computed standardized parameter esti-
mates. For adults, all variables were included
in the respective model. For children, a step-
wise procedure (SAS Institute Inc. 2004) was
used to identify signiﬁcant regressors. All data
were analyzed using statistical software pack-
age SAS version 9.1.3 (SAS Institute Inc.,
Cary, NC, USA).
Results
One hundred ninety-nine men in Arnsberg
(85% of all men who were successfully con-
tacted) and 200 men (68%) in Brilon
answered the questionnaire and gave their
consent to participate. One hundred three
blood samples were drawn from men in
Brilon and 101 in Arnsberg.
One hundred seventy-four mother–child
pairs (80%) in Arnsberg and 182 (70%) in
Siegen gave their consent to participate. One
hundred ﬁfty-three blood samples were drawn
from mothers and 80 from children in Siegen,
and 164 and 90 in Arnsberg (Table 1).
Age, height, body weight and sex were
comparable between Arnsberg and the refer-
ence groups in Siegen and Brilon (Table 2). 
PFOA and PFOS were not detected in
drinking-water samples from reference areas
Siegen and Brilon (Figure 1). After installa-
tion of activated charcoal ﬁlters in the water-
works, PFOA concentrations in Arnsberg
were significantly reduced. However, during
the study period, filtration performance
declined and PFOA concentrations in tap-
water samples increased from below the LOD
to 71 ng/L.
All measured PFOA and PFOS concentra-
tions in blood plasma exceeded the LOD
(0.1 µg/L). PFPA and PFHxA were not
detected in any of the samples (LOD: 1 µg/L). 
PFOA levels of children and adults living in
Arnsberg were 4.5–8.3 times higher compared
with the reference population (ratios based on
arithmetic means: children 24.6/5.2 µg/L,
mothers 26.7/3.2 µg/L, men 28.5/6.4 µg/L,
Table 3). 
PFOS concentrations were not signifi-
cantly different in the groups of the men and
the children (p = 0.30 for both groups).
However, in the blood of mothers in
Arnsberg, 12% higher PFOS concentrations
were observed compared with the control area
in Siegen (p < 0.05, Table 3). 
PFHxS concentrations were significantly
increased in Arnsberg compared with the
respective reference areas (p < 0.05, Table 3).
Hölzer et al.
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Table 1. Sampling, selection criteria, and response rates in Arnsberg and reference areas (Siegen
and Brilon).
Mother–child pairsa Men (18–69 years)b
Characteristic Siegen Arnsberg Brilon Arnsberg
Size of selected populations (no.) 417 364 8,608 14,167
No. of subjects
Received the information letter 417 364 500 527
Were contacted successfully 262 217 296 234
Gave consent to participate 182 174 200 199
Refused consent 80 43 96 35
Filled in nonresponder questionnaire 51 16 58 16
Blood samples
Mothers 153 164 
Children 80 90
Men 103 101
aSample included all mother–child (school beginners) pairs in selected districts. bAge-stratiﬁed random sample.
Table 2. Characteristics of study groups in Arnsberg and reference areas (Siegen and Brilon).
Children Mothers Men
Characteristic Siegen Arnsberg Siegen Arnsberg Brilon Arnsberg
No. 80 90 153 164 103 101
Male:female (%) 57:43 54:46
Age (years, mean) 5.7 5.8 35.4 36.2 47.9 47.1
Body weight (kg, mean) 20.9 21.8 68.2 69.8 86.4 85.4
Height (cm, mean) 116.7 118.2 166.7 167.8 179.4 181.1
Table 3. PFC concentrations in blood plasma of study populations in Arnsberg and reference areas
(Brilon, Siegen). 
No. No. < LOD AM SD Min 75th 95th Max GM 95% CI
PFOA (µg/L)
Children
Siegen 80 0 5.2 2.1 2.0 6.5 9.1 11.5 4.8 4.4–5.2
Arnsberg 90 0 24.6 12.9 6.7 29.4 46.3 96.6 22.1 20.1–24.4
Mothers
Siegen 153 0 3.2 1.5 0.7 4.1 5.9 9.2 2.8 2.6–3.1
Arnsberg 164 0 26.7 13.8 5.4 32.7 52.4 99.7 23.4 21.6–25.4
Men
Brilon 103 0 6.4 2.8 1.1 8.3 10.9 15.3 5.8 5.3–6.3
Arnsberg 101 0 28.5 12.9 6.1 38.4 46.6 77.5 25.3 22.9–28.0
PFOS (µg/L)
Children
Siegen 80 0 5.2 3.4 1.6 6.1 11.5 26.2 4.6 4.1–5.1
Arnsberg 90 0 5.4 2.9 2.4 6.0 10.5 20.6 4.9 4.5–5.4
Mothers
Siegen 153 0 6.2 6.2 1.0 7.3 13.5 70.7 5.2 4.7–5.6
Arnsberg 164 0 6.3 2.8 1.7 7.6 11.5 16.7 5.8 5.4–6.2
Men
Brilon 103 0 12.4 11.5 1.7 14.0 26.4 92.5 9.7 8.5–11.0
Arnsberg 101 0 11.8 6.1 2.7 14.8 23.4 36.2 10.5 9.6–11.6
PFHxS (µg/L)
Children
Siegen 80 1 1.0 1.1 < LOD 1.0 2.2 9.1 0.8 0.7–0.9
Arnsberg 90 0 1.4 1.5 0.5 1.5 2.1 13.4 1.2 1.1–1.3
Mothers
Siegen 153 2 0.7 0.4 < LOD 0.9 1.5 2.1 0.6 0.6–0.7
Arnsberg 164 2 1.2 0.6 < LOD 1.5 2.2 5.7 1.1 1.0–1.2
Men
Brilon 103 0 2.4 1.0 0.7 3.0 4.3 5.4 2.2 2.0–2.4
Arnsberg 101 0 2.7 1.1 0.7 3.2 4.4 8.7 2.5 2.3–2.8
Abbreviations: AM, arithmetic mean; GM, geometric mean; Max, maximum; Min, minimum; 95% CI, 95% conﬁdence inter-
val of the geometric mean. 75th and 95th are percentiles. LOD = 0.1 µg/L. In Arnsberg, the PFHxS concentrations were
14% (men), 53% (children), and 80%
(mothers, geometric mean) higher.
PFBS was detected in 33% of the blood
samples of children, 4% of the women, and
13% of the men in Arnsberg compared with
5%, 0.7%, and 3%, respectively, in the refer-
ence areas (data not shown). The proportion
of concentrations above the LOD (0.1 µg/L)
was higher in Arnsberg compared with the
reference areas (p < 0.05, Fisher’s exact test).
The maximum PFBS concentration detected
in a blood sample was 0.46 µg/L. Ninety-ﬁfth
percentiles of PFBS concentrations observed
in children in Arnsberg were 0.2 µg/L, for
women, < LOD, and for men, 0.2 µg/L
compared with 0.1 µg/L, < LOD, and
< LOD, respectively, in the reference areas.
PFOA levels were associated with
increased PFOS and PFHxS concentrations.
This effect was most pronounced in the refer-
ence areas [rS = 0.54/0.77 (children), 0.62/
0.57 (mothers), 0.53/0.49 (men); p < 0.01].
In Arnsberg, the associations were weaker
[rS = 0.32/0.37 (children), not significant/
0.50 (mothers), 0.27/0.49 (men); p < 0.01]
(Table 4). 
Statistically signiﬁcant (p < 0.01) correla-
tions existed between age and PFOA (moth-
ers and men in both areas), PFOS (men in
both areas, mothers in the reference area), and
PFHxS (men in both areas, mothers in
Arnsberg) (Table 4). 
Consumption of drinking (tap) water was
clearly associated with raised PFOA concentra-
tions in blood plasma in Arnsberg (Figure 2).
The more tap water was consumed at home,
the higher PFOA concentrations we observed
in blood plasma. Study participants who
reported drinking > 1.5 L tap water daily had
about 2-fold increased PFOA plasma levels
compared with those who reported drinking
< 0.25 L/day [median plasma concentrations
(µg PFOA/L): children, 35 (n = 8)/18 (n =
38); women, 31 (n = 35)/13 (n = 11); men,
41 (n = 28)/15 (n = 11)].
Table 5 presents characteristics of linear
regression models of PFC concentrations in
plasma samples of adults. Consumption of
drinking water at home, locally grown fruits
and vegetables, fish caught from local lakes,
age, sex, BMI, and area (Arnsberg, reference
area) were chosen as independent variables.
The proportions of variance of PFOA, PFOS,
or PFHxS, which were predictable from the
regressor variables, varied between 0.27 and
0.79 (adjusted R2). PFOA levels in adults were
associated with consumption of drinking
water at home (p < 0.01), locally grown fruits
and vegetables (p = 0.059), age, male sex,
region (all p < 0.01), and inversely with BMI
(p = 0.05). Age, male sex, region, and
consumption of locally caught fish (all
PFC biomonitoring in children and adults
Environmental Health Perspectives • VOLUME 116 | NUMBER 5 | May 2008 655
Table 4. Spearman rank correlation coefﬁcients for PFOA, PFOS, PFHxS, BMI, and age.  
PFOA PFOS PFHxS BMI Age
Men
Reference area (n = 103) Arnsberg (n = 101)
PFOA 0.27** 0.49** 0.09 0.43**
PFOS 0.53** 0.48** –0.26** 0.26**
PFHxS 0.49** 0.64** 0.02 0.31**
BMI 0.03 0.11 0.12 0.30**
Age 0.42** 0.40** 0.27** 0.30**
Mothers
Reference area (n = 153) Arnsberg (n = 164)
PFOA 0.11 0.50** –0.19* 0.19*
PFOS 0.62** 0.43** –0.11 0.11 
PFHxS 0.57** 0.58** 0.002 0.23**
BMI –0.10 –0.09 0.03 0.04 
Age 0.27** 0.18* 0.09 0.001
Children
Reference area (n = 80) Arnsberg (n = 90)
PFOA 0.32** 0.37** 0.02 –0.07 
PFOS 0.54** 0.56** 0.07 0.02 
PFHxS 0.77** 0.68** 0.03 0.10
BMI –0.16 –0.23# –0.25* –0.10 
Age 0.18 0.21# 0.14 –0.08
Prob > |r| under H0: Rho = 0. *0.05 > p ≥ 0.01. **p < 0.01. #0.1 > p ≥ 0.05. 
Figure 2. Self-assessed consumption of drinking water at home and PFOA, PFOS, and PFHxS concentra-
tions in blood plasma (median) in Arnsberg.
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Drinking-water consumption at home (L/day)
Mothers Children Men
PFOS
PFOA
PFHxS
Table 5. Results of multiple regression analysis on PFOA , PFOS, and PFHxS concentrations in blood plasma samples of adults.
log10[PFOA (ng/L)] log10[PFOS (ng/L)] log10[PFHxS (ng/L)]
β 95% CI SE β 95% CI SE β 95% CI SE
Consumption of drinking water (L/day) 0.062** 0.040 to 0.083 0.12 –0.007 –0.030 to 0.016 –0.02 0.020# –0.001 to 0.042 0.06
Consumption of locally grown fruits and vegetables (per week) 0.005# 0.0002 to 0.011 0.04 –0.0001 –0.006 to 0.006 –0.001 0.002 –0.003 to 0.008 0.02
Consumption of locally caught ﬁsh (per week) 0.059 –0.027 to 0.144 0.03 0.123** 0.030 to 0.216 0.10 0.037 –0.049 to 0.123 0.03
BMI (kg/m2) –0.004* –0.009 to 0.0003 –0.05 –0.006* –0.010 to –0.001 –0.10 –0.001 –0.005 to 0.003 –0.01
Age (years) 0.007** 0.005 to 0.009 0.17 0.006** 0.004 to 0.008 0.25 0.005** 0.003 to 0.007 0.18
Male sex 0.074** 0.029 to 0.119 0.08 0.195** 0.147 to 0.244 0.36 0.384** 0.339 to 0.429 0.60
Region (Arnsberg) 0.801** 0.763 to 0.840 0.87 0.030 –0.012 to 0.072 0.06 0.159** 0.120 to 0.197 0.25
Abbreviations: β, parameter estimates; 95% CI, 95% confidence interval of the parameter estimate; SE, standardized estimate. Adjusted R2 = 0.79 ng/L for log10(PFOA), 0.27 for
log10(PFOS), and 0.55 for log10(PFHxS).
*0.01 ≤ p < 0.05. **p < 0.01. #0.05 ≤ p < 0.1.p < 0.01), and (inversely) BMI (p = 0.02) were
predictors of PFOS concentrations in adults.
PFHxS was associated with consumption of
drinking water (p = 0.066), male sex, age, and
study area (all p < 0.01).
In children, PFOA concentrations in blood
plasma were associated with drinking water
consumption at home and region (p < 0.01,
adjusted R 2 = 0.75). Region (p < 0.01) and
male sex (p = 0.07) were regressors for internal
exposure of children to PFHxS (adjusted R2 =
0.16), whereas none of the independent vari-
ables mentioned was significantly associated
with PFOS concentrations in blood plasma of
children. No statistically significant asso-
ciation was found between PFOA or PFOS
and smoking status (adults) or exposure to
environmental tobacco smoke (children, data
not shown).
Discussion
Several limitations must be considered with
regard to eligible exact exposure quantifica-
tion. Local authorities informed the public
about the contamination of the drinking
water in May 2006. On receiving this infor-
mation, > 50% of the mother–child pairs and
> 25% of the men in Arnsberg reduced their
personal drinking-water consumption, for
example by using bottled water. Blood sam-
ples were collected in October 2006, that is,
5 months after publication of the ﬁrst reports
on the PFOA contamination and 3 months
after distinct reductions in the exposure situa-
tion had taken place. However, PFC half-lives
in humans presumably are long and probably
unaffected by short-term changes. Based on a
5-year follow-up of 26 retired ﬂuorochemical
production workers, Olsen et al. (2007)
recently calculated the geometric mean half-
lives of human serum elimination of 4.8 years
for PFOS, 7.3 years for PFHxS, and 3.5 years
for PFOA.
We do not know how many years the
PFOA contamination of the drinking water
had already lasted and whether the PFOA levels
in drinking water might have been even higher
during the most recent years. Questionnaire
data on drinking-water-consumption behavior
before May 2006 are the best data available and
therefore were chosen as a proxy measurement
for exposure. Tap-water consumption assessed
by interview compared fairly well with standard
exposure factors published by the National
Center for Environmental Assessment
(NCEA), Ofﬁce of Research and Development
of the U.S. Environmental Protection Agency.
Interview-derived mean tap water consumption
rates of children (mothers, men) were 0.7 (1.2,
1.4) L/day; NCEA-recommended drinking
water intakes rates were 0.7 L/day for children
1–10 years of age and 1.4 L/day for adults
(NCEA 1997). 
We assessed drinking-water use by an
interview based on a structured questionnaire.
Such information is subject to over- and
underreporting, particularly in this case,
because the participants in Arnsberg may have
been especially aware of that route of expo-
sure because of the media coverage. 
The statistical association between con-
sumption of locally caught fish and PFOS
blood concentrations seems plausible. Several
reports on elevated PFOS concentrations in
ﬁsh and on the biomagniﬁcation potential of
PFCs have been published recently. Nakata
et al. (2006) investigated PFC in sediments
and aquatic organisms of the Ariake Sea,
Japan. They reported PFOS as the dominant
contaminant and observed elevated concen-
trations in higher trophic level species.
Sinclair et al. (2006) found average concen-
trations of PFOS in ﬁsh that were 8,850-fold
greater than those in surface waters from New
York State. Haukas et al. (2007) reported bio-
magniﬁcation factors > 1 for PFHxS, perﬂuo-
rononanoic acid, PFOS, and the sum of
polyfluorinated alkyl substances in selected
species from the Barents Sea food web. PFC
concentrations up to 425 µg PFOS and up to
12 µg PFOA/kg wet weight were observed in
fish caught in the upper Moehne and in the
Lake Moehnesee (Wilhelm et al., in press). 
The ﬁrst human biomonitoring study that
assessed drinking water as a source of exposure
to PFCs was carried out in Little Hocking,
Ohio, (Emmett et al. 2006a, 2006b). During
the investigation period from 2002 to 2005, a
mean concentration of 3,500 ng PFOA/L
(range, 1,500–7,200 ng/L) in drinking water
was reported. This level is about 7-fold higher
than the highest concentrations measured in
drinking water samples in Arnsberg in May
2006. PFOA concentrations in serum of the
population in Little Hocking (people who
were supplied by the Little Hocking water
system only; arithmetic mean, 448 µg/L;
n = 291) are about 16- to 18-fold increased
compared with the mean plasma levels of the
population in Arnsberg. 
Plasma and serum concentrations of
PFOA, PFOS, and PFHxS have been found
comparable (Ehresman et al. 2007). Most
national and international studies use these
biological matrices. The PFOA concentrations
in our reference groups compare well with
data from other actual German studies and to
the NHANES 2003–2004 data (Calafat et al.
2007; Fromme et al. 2007a; Midasch et al.
2006) (Figure 3). 
Conclusion
This cross-sectional study demonstrated dis-
tinctly elevated PFC concentrations in blood
plasma of children and adults exposed to
PFC-contaminated drinking water in an envi-
ronmental setting. Because of the origin of
the contamination—the disposal of PFC-
contaminated soil conditioner on agricultural
areas that drain into a drinking water reser-
voir—precise data about the PFC concentra-
tions in drinking water have been available
since the ﬁrst detection of the PFC contami-
nation in May 2006.
Of the various PFCs, PFOA was the main
compound found in drinking water (500–640
ng/L). PFOA levels in blood plasma of resi-
dents living in Arnsberg were 4.5–8.3 times
higher than in the reference population. In
this respect, our study provides afﬁrmation to
the publication of Emmett et al. (2006a) but
on a much lower level of exposure (about one-
seventeenth with regard to blood levels, about
one-seventh concerning drinking-water con-
centrations). PFHxS concentrations were sig-
nificantly increased in Arnsberg compared
with controls (p < 0.05). PFBS was detected in
33% of the children, 4% of the women, and
13% of the men in Arnsberg compared with
5%, 0.7%, and 3%, respectively, in the refer-
ence areas (p < 0.05). PFOS concentrations
were not signiﬁcantly different in the groups
of the men and the children (p = 0.30 for both
groups). However, in the blood of mothers in
Arnsberg, 12% higher PFOS concentrations
were observed compared with the control area
in Siegen (p < 0.05, Table 3). Age and male
sex were significant predictors of PFOS,
PFOA, and PFHxS; associations of other
regressors (diet, BMI) varied among PFCs. 
Hölzer et al.
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Figure 3. PFOA concentrations in human blood in Arnsberg and reference areas compared with national
and international data. 
*Median instead of geometric mean.
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